Human Pathology
Volume 41, Issue 12 , Pages 1682-1693 , December 2010

Activation of the transcription factor c-Jun in acute cellular and antibody-mediated rejection after kidney transplantation

  • Akimitsu Kobayashi, MD

      Affiliations

    • Division of Kidney and Hypertension, Department of Internal Medicine, The Jikei, University School of Medicine, Tokyo 105-8471, Japan
    • Corresponding Author InformationCorresponding author.
    • ,
  • Takamune Takahashi, MD, PhD

      Affiliations

    • Division of Nephrology and Hypertension, Vanderbilt University Medical Center, Nashville, TN 37232, USA
    • ,
  • Shigeru Horita

      Affiliations

    • Kidney Center, Tokyo Women's Medical University, Tokyo 162-8666, Japan
    • ,
  • Izumi Yamamoto, MD

      Affiliations

    • Division of Kidney and Hypertension, Department of Internal Medicine, The Jikei, University School of Medicine, Tokyo 105-8471, Japan
    • ,
  • Hiroyasu Yamamoto, MD, PhD

      Affiliations

    • Division of Kidney and Hypertension, Department of Internal Medicine, The Jikei, University School of Medicine, Tokyo 105-8471, Japan
    • ,
  • Satoshi Teraoka, MD, PhD

      Affiliations

    • Department of Surgery, Tokyo Women's Medical University, Tokyo 162-8666, Japan
    • ,
  • Kazunari Tanabe, MD, PhD

      Affiliations

    • Department of Urology, Tokyo Women's Medical University, Tokyo 162-8666, Japan
    • ,
  • Tatsuo Hosoya, MD, PhD

      Affiliations

    • Division of Kidney and Hypertension, Department of Internal Medicine, The Jikei, University School of Medicine, Tokyo 105-8471, Japan
    • ,
  • Yutaka Yamaguchi, MD

      Affiliations

    • Department of Pathology, Kashiwa Hospital, The Jikei University School of Medicine, Chiba 277-8567, Japan

Received 10 February 2010 ,Revised 13 April 2010 ,Accepted 30 April 2010.

References 

  1. Mizui M, Isaka Y, Takabatake Y, et al. Transcription factor Ets-1 is essential for mesangial matrix remodeling. Kidney Int. 2006;70:298–305
  2. Sakurai H, Shigemori N, Hisada Y, Ishizuka T, Kawashima K, Sugita T. Suppression of NF-kappa B and AP-1 activation by glucocorticoids in experimental glomerulonephritis in rats: molecular mechanisms of anti-nephritic action. Biochim Biophys Acta. 1997;1362:252–262
  3. Fujihara CK, Antunes GR, Mattar AL, Malheiros DM, Vieira JM, Zatz R. Chronic inhibition of nuclear factor-kappaB attenuates renal injury in the 5/6 renal ablation model. Am J Physiol Renal Physiol. 2007;292:F92–F99
  4. Hernández-Presa MA, Gómez-Guerrero C, Egido J. In situ non-radioactive detection of nuclear factors in paraffin sections by Southwestern histochemistry. Kidney Int. 1999;55:209–214
  5. Karin M. The regulation of AP-1 activity by mitogen-activated protein kinases. J Biol Chem. 1995;270:16483–16486
  6. Karin M, Liu Z, Zandi E. Ap-1 function and regulation. Curr Opin Cell Biol. 1997;9:240–246
  7. Smeal T, Binetruy B, Mercola DA, Birrer M, Karin M. Oncogenic and transcriptional cooperation with Ha-Ras requires phosphorylation of c-Jun on serines 63 and 73. Nature. 1991;354:494–496
  8. Dérijard B, Hibi M, Wu IH, et al. JNK1: a protein kinase stimulated by UV light and Ha-Ras that binds and phosphorylates the c-Jun activation domain. Cell. 1994;76:1025–1037
  9. Stambe C, Atkins RC, Tesch GH, et al. Activation and cellular localization of the p38 and JNK MAPK pathways in rat crescentic glomerulonephritis. Kidney Int. 2003;64:2121–2132
  10. Park SJ, Jeong KS. Cell-type-specific activation of mitogen-activated protein kinases in PAN-induced progressive renal disease in rats. Biochem Biophys Res Commun. 2004;323:1–8
  11. Ma FY, Flanc RS, Tesch GH, et al. A pathogenic role for c-Jun amino-terminal kinase signaling in renal fibrosis and tubular cell apoptosis. J Am Soc Nephrol. 2007;18:472–484
  12. De Borst MH, Prakash J, Melenhorst WB, et al. Glomerular and tubular induction of the transcription factor c-Jun in human renal disease. J Pathol. 2007;213:219–228
  13. Flanc RS, Ma FY, Tesch GH, et al. A pathogenic role for JNK signaling in experimental anti-GBM glomerulonephritis. Kidney Int. 2007;72:698–708
  14. Tabata A, Morikawa M, Miyajima M, et al. Suppression of alloreactivity and allograft rejection by SP600125, a small molecule inhibitor of c-Jun N-terminal kinase. Transplantation. 2007;83:1358–1364
  15. Solez K, Colvin RB, Racusen LC, et al. Banff '05 Meeting Report: differential diagnosis of chronic allograft injury and elimination of chronic allograft nephropathy (‘CAN’). Am J Transplant. 2007;7:518–526
  16. Azuma H, Paul LC, Tilney NL. Insights into acute and chronic rejection. Transplant Proc. 1996;28:2081–2084
  17. Pattison JM, Krensky AM. New insights into mechanisms of allograft rejection. Am J Med Sci. 1997;313:257–263
  18. Dong C, Yang DD, Tournier C, et al. JNK is required for effector T-cell function but not for T-cell activation. Nature. 2000;405:91–94
  19. Salh B. c-Jun N-terminal kinases as potential therapeutic targets. Expert Opin Ther Targets. 2007;11:1339–1353
  20. Arbour N, Naniche D, Homann D, Davis RJ, Flavell RA, Oldstone MB. c-Jun NH(2)-terminal kinase (JNK)1 and JNK2 signaling pathways have divergent roles in CD8(+) T cell-mediated antiviral immunity. J Exp Med. 2002;195:801–810
  21. Trpkov K, Campbell P, Pazderka F, Cockfield S, Solez K, Halloran PF. Pathologic features of acute renal allograft rejection associated with donor-specific antibody. Analysis using the Banff grading schema. Transplantation. 1996;61:1586–1592
  22. Mauiyyedi S, Crespo M, Collins AB, et al. Acute humoral rejection in kidney transplantation: II. Morphology, immunopathology, and pathologic classification. J Am Soc Nephrol. 2002;13:779–787
  23. Regele H, Exner M, Watschinger B, et al. Endothelial C4d deposition is associated with inferior kidney allograft outcome independently of cellular rejection. Nephrol Dial Transplant. 2001;16:2058–2066
  24. Magil AB. Infiltrating cell types in transplant glomerulitis: relationship to peritubular capillary C4d deposition. Am J Kidney Dis. 2005;45:1084–1089
  25. Magil AB, Tinckam K. Monocytes and peritubular capillary C4d deposition in acute renal allograft rejection. Kidney Int. 2003;63:1888–1893
  26. Yanagisawa T, Otsubo O, Shimada T, et al. Relationship between macrophage infiltration of renal allografts and chronic renal impairment. Transplant Proc. 1997;29:2783–2786
  27. Peng H, Takano T, Papillon J, Bijian K, Khadir A, Cybulsky AV. Complement activates the c-Jun N-terminal kinase/stress-activated protein kinase in glomerular epithelial cells. J Immunol. 2002;169:2594–2601
  28. Kitamura M. Endoplasmic reticulum stress in the kidney. Clin Exp Nephrol. 2008;12:317–325
  29. Wang N, Verna L, Hardy S, Forsayeth J, Zhu Y, Stemerman MB. Adenovirus-mediated overexpression of c-Jun and c-Fos induces intercellular adhesion molecule-1 and monocyte chemoattractant protein-1 in human endothelial cells. Arterioscler Thromb Vasc Biol. 1999;19:2078–2084
  30. Pelaia G, Cuda G, Vatrella A, et al. Effects of glucocorticoids on activation of c-jun N-terminal, extracellular signal-regulated, and p38 MAP kinases in human pulmonary endothelial cells. Biochem Pharmacol. 2001;62:1719–1724
  31. DiMari J, Megyesi J, Udvarhelyi N, Price P, Davis R, Safirstein R. N-Acetyl cysteine ameliorates ischemic renal failure. Am J Physiol. 1997;272:F292–F298
  32. Pombo CM, Bonventre JV, Avruch J, Woodgett JR, Kyriakis JM, Force T. The stress-activated protein kinases are major c-Jun amino-terminal kinases activated by ischemia and reperfusion. J Biol Chem. 1994;269:26546–26551
  33. Wang L, Matsushita K, Araki I, Takeda M. Inhibition of c-Jun N-terminal kinase ameliorates apoptosis induced by hydrogen peroxide in the kidney tubule epithelial cells (NRK-52E). Nephron. 2002;91:142–147
  34. Vongwiwatana A, Tasanarong A, Rayner DC, Melk A, Halloran PF. Epithelial to mesenchymal transition during late deterioration of human kidney transplants: the role of tubular cells in fibrogenesis. Am J Transplant. 2005;5:1367–1374
  35. Ma FY, Flanc RS, Tesch GH, Bennett BL, Friedman GC, Nikolic-Paterson DJ. Blockade of the c-Jun amino terminal kinase prevents crescent formation and halts established anti-GBM glomerulonephritis in the rat. Lab Invest. 2009;89:470–484

☆ This work had no funding support and the authors report no conflict of interest.

PII: S0046-8177(10)00166-8

doi: 10.1016/j.humpath.2010.04.016

Human Pathology
Volume 41, Issue 12 , Pages 1682-1693 , December 2010

Article Tools

* Image Usage & Resolution